Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome)

Journal of Autoimmunity

Volumn 48-49, Issue , 2014, Pages 99-103

  Mouthon, Luc ^a   Dunogue, Bertrand ^a   Guillevin, Loïc ^a  

^a INSTITUT COCHIN   (France)

Author keywords

ANCA; Churg Strauss syndrome; Classification; Diagnosis criteria; Eosinophilic granulomatosis with polyangiitis

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; MYELOPEROXIDASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR;

ALLERGY; ARTICLE; ASTHMA; CHURG STRAUSS SYNDROME; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EOSINOPHILIA; EOSINOPHILIC GRANULOMA; EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS; GLOMERULONEPHRITIS; HUMAN; HYPEREOSINOPHILIA; HYPEREOSINOPHILIC SYNDROME; INCIDENCE; LUNG HEMORRHAGE; LUNG INFILTRATE; MONONEUROPATHY MULTIPLEX; OBSERVATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PARANASAL SINUSITIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; VASCULITIS;

ANCA; CHURG-STRAUSS SYNDROME; CLASSIFICATION; DIAGNOSIS CRITERIA; EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS;

CHURG-STRAUSS SYNDROME; DIAGNOSIS, DIFFERENTIAL; HUMANS; INCIDENCE; MICROSCOPIC POLYANGIITIS; PREVALENCE; TERMINOLOGY AS TOPIC;

EID: 84895895186     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2014.01.018     Document Type: Article

References (44)

1. Churg J., Strauss L. Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 1951, 27:277-301.
2. Masi A.T., Hunder G.G., Lie J.T., Michel B.A., Bloch D.A., et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990, 33:1094-1100.
3. Jennette J.C., Falk R.J., Andrassy K., Bacon P.A., Churg J., et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994, 37:187-192.
4. Guillevin L., Cohen P., Gayraud M., Lhote F., Jarrousse B., et al. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999, 78:26-37.
5. Comarmond C., Pagnoux C., Khellaf M., Cordier J.F., Hamidou M., et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group Cohort. Arthritis Rheum 2013, 65:270-281.
6. Moosig F., Bremer J.P., Hellmich B., Holle J.U., Holl-Ulrich K., et al. Avasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients. Ann Rheum Dis 2013, 72:1011-1017.
7. Sablé-Fourtassou R., Cohen P., Mahr A., Pagnoux P., Mouthon L., et al. Antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Ann Intern Med 2005, 143:632-638.
8. Sinico R.A., Di Toma L., Maggiore U., Bottero P., Radice A., et al. Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome. Arthritis Rheum 2005, 52:2926-2935.
9. Guillevin L., Pagnoux C., Seror R., Mahr A., Mouthon L., et al. The five-factor score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 2011, 90:19-27.
10. Mahr A., Guillevin L., Poissonnet M., Ayme S. Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate. Arthritis Rheum 2004, 51:92-99.
11. Haugeberg G., Bie R., Bendvold A., Larsen A.S., Johnsen V. Primary vasculitis in a Norwegian community hospital: a retrospective study. Clin Rheumatol 1998, 17:364-368.
12. Martin R.M., Wilton L.V., Mann R.D. Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies. Pharmacoepidemiol Drug Saf 1999, 8:179-189.
13. Watts R.A., Lane S.E., Bentham G., Scott D.G. Epidemiology of systemic vasculitis: a ten-year study in the United Kingdom. Arthritis Rheum 2000, 43:414-419.
14. Watts R.A., Lane S., Scott D.G. What is known about the epidemiology of the vasculitides?. Best Pract Res Clin Rheumatol 2005, 19:191-207.
15. Harrold L.R., Andrade S.E., Go A.S., Buist A.S., Eisner M., et al. Incidence of Churg-Strauss syndrome in asthma drug users: a population-based perspective. JRheumatol 2005, 32:1076-1080.
16. Dietz A., Hubner C., Andrassy K. Macrolide antibiotic-induced vasculitis (Churg-Strauss syndrome). Laryngorhinootologie 1998, 77:111-114.
17. Imai H., Nakamoto Y., Hirokawa M., Akihama T., Miura A.B. Carbamazepine-induced granulomatous necrotizing angiitis with acute renal failure. Nephron 1989, 51:405-408.
18. Mathur S., Dooley J., Scheuer P.J. Quinine induced granulomatous hepatitis and vasculitis. BMJ 1990, 300:613.
19. Guillevin L., Guittard T., Bletry O., Godeau P., Rosenthal P. Systemic necrotizing angiitis with asthma: causes and precipitating factors in 43 cases. Lung 1987, 165:165-172.
20. Green R.L., Vayonis A.G. Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment. Lancet 1999, 353:725-726.
21. Franco J., Artes M.J. Pulmonary eosinophilia associated with montelukast. Thorax 1999, 54:558-560.
22. Wechsler M.E., Drazen J.M. Zafirlukast and Churg-Strauss syndrome. Chest 1999, 116:266-267.
23. Wechsler M.E., Finn D., Gunawardena D., Westlake R., Barker A., et al. Churg-Strauss syndrome in patients receiving montelukast as treatment for asthma. Chest 2000, 117:708-713.
24. Wechsler M.E., Wong D.A., Miller M.K., Lawrence-Miyasaki L. Churg-strauss syndrome in patients treated with omalizumab. Chest 2009, 136:507-518.
25. Giavina-Bianchi P., Giavina-Bianchi M., Agondi R., Kalil J. Administration of anti-IgE to a Churg-Strauss syndrome patient. Int Arch Allergy Immunol 2007, 144:155-158.
26. Puechal X., Rivereau P., Vinchon F. Churg-Strauss syndrome associated with omalizumab. Eur J Intern Med 2008, 19:364-366.
27. Hauser T., Mahr A., Metzler C., Coste J., Sommerstein R., et al. The leucotriene receptor antagonist montelukast and the risk of Churg-Strauss syndrome: a case-crossover study. Thorax 2008, 63:677-682.
28. Kostianovsky A., Charles P., Alves J.F., Goulet M., Pagnoux C., et al. Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients. Clin Exp Rheumatol 2012, 30:S83-S89.
29. Lanham J.G., Elkon K.B., Pusey C.D., Hughes G.R. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore) 1984, 63:65-81.
30. Chumbley L.C., Harrison E.G., DeRemee R.A. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1977, 52:477-484.
31. Gaskin G., Clutterbuck E.J., Pusey C.D. Renal disease in the Churg-Strauss syndrome. Diagnosis, management and outcome. Contrib Nephrol 1991, 94:58-65.
32. Haas C., Geneau C., Odinot J.M., De Jaeger C., Lavner M., et al. Allergic angiitis with granulomatosis: Churg-Strauss syndrome. Retrospective study of 16 cases. Ann Med Interne (Paris) 1991, 142:335-342.
33. Abu-Shakra M., Smythe H., Lewtas J., Badley E., Weber D., et al. Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum 1994, 37:1798-1803.
34. Wallaert B., Gosset P., Prin L., Bart F., Marquette C.H., et al. Bronchoalveolar lavage in allergic granulomatosis and angiitis. Eur Respir J 1993, 6:413-417.
35. Marmursztejn J., Vignaux O., Cohen P., Guilpain P., Pagnoux C., et al. Impact of cardiac magnetic resonance imaging for assessment of Churg-Strauss syndrome: a cross-sectional study in 20 patients. Clin Exp Rheumatol 2009, 27:S70-S76.
36. Marmursztejn J., Cohen P., Duboc D., Pagnoux C., Mouthon L., et al. Cardiac magnetic resonance imaging in Churg-Strauss-syndrome. Impact of immunosuppressants on outcome assessed in a prospective study on 8 patients. Clin Exp Rheumatol 2010, 28:8-13.
37. Jennette J.C., Falk R.J., Bacon P.A., Basu N., Cid M.C., et al. 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 2013, 65:1-11.
38. Guillevin L. Vasculitis: time of changes. Presse Med 2012, 41:934-936.
39. Cottin V., Cordier J.F. Eosinophilic pneumonias. Allergy 2005, 60:841-857.
40. Roufosse F., Cogan E., Goldman M. The hypereosinophilic syndrome revisited. Annu Rev Med 2003, 54:169-184.
41. Hoffman G.S., Kerr G.S., Leavitt R.Y., Hallahan C.W., Lebovics R.S., et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992, 116:488-498.
42. Samson M., Puechal X., Devilliers H., Ribi C., Cohen P., et al. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials. JAutoimmun 2013, 43:60-69.
43. Cohen P., Pagnoux C., Mahr A., Arene J.P., Mouthon L., et al. Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients. Arthritis Rheum 2007, 57:686-693.
44. Guillevin L., Lhote F., Gayraud M., Cohen P., Jarrousse B., et al. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996, 75:17-28.